Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2016 Financial Results

Go back to Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2016 Financial Results
JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) Delayed: 224.66 -2.27 (1%)
Previous Close $226.93    52 Week High $160.00 
Open $227.47    52 Week Low $95.80 
Day High $228.00    P/E 41.76 
Day Low $220.74    EPS $5.38 
Volume 1,906,922